FDA Grants Approval for Tofacitinib Citrate ANDA219530 by Macleods Pharmaceuticals
The FDA has granted approval for ANDA219530, a generic version of Tofacitinib Citrate, submitted by Macleods Pharmaceuticals.
Company
Pharmaceutical intelligence for Macleods Pharmaceuticals with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.